Delivery of extracellular vesicle–associated microRNA-146a regulates human monocyte phenotype and function

K Kyle I Mentkowski (Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,) T Touba Tarvirdizadeh (Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,) R Rohan Pandey P Paul J Schiffmacher (Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,) S Sara Hough (Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,) L Lisa A Eagler (Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,) F Fraser J Sim (Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,) J Jessica Reynolds (Department of Medicine, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,) J Jennifer K Lang (Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,)

Abstract

Abstract CCR2+ monocytes are recruited to sites of acute myocardial injury, where they play a critical role in clearing necrotic debris and replenishing the depleted resident macrophage population. Although this response is necessary for early tissue repair, prolonged activation of inflammatory pathways and persistent recruitment of CCR2+ monocytes have been associated with accelerated ventricular remodeling and adverse outcomes. Inhibition of CCR2 has shown promise in preclinical models of myocardial injury and represents a potential therapeutic target. Cardiosphere-derived cell extracellular vesicles (CDC-EVs) have demonstrated cardioprotective effects partly through modulation of the immune response. We investigated whether CDC-EVs regulate inflammatory monocyte trafficking through effects on CCR2 signaling. We found that CDC-EVs reduce the surface availability of CCR2 on human monocytes through an miR-146a–dependent mechanism, resulting in decreased monocyte migration toward CCL2. These findings identify a previously unrecognized mechanism by which CDC-EVs modulate CCR2-dependent monocyte trafficking and provide new insight into how EVs regulate innate immune responses after myocardial injury.

Article Details

Volume / Issue Vol. 215, Issue 8
Published August 04, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (9)

K

Kyle I Mentkowski

Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,

T

Touba Tarvirdizadeh

Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,

R

Rohan Pandey

P

Paul J Schiffmacher

Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,

S

Sara Hough

Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,

L

Lisa A Eagler

Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,

F

Fraser J Sim

Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,

J

Jessica Reynolds

Department of Medicine, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,

J

Jennifer K Lang

Department of Medicine, Division of Cardiology, Jacobs School of Medicine and Biomedical Sciences , Buffalo, NY,